128
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Prospective observational multi-poison center study of ziprasidone exposures

, M.P.H. , Pharm.D., , Pharm.D., , Pharm.D., , R.N. , M.S. & , M.P.H. , Pharm.D.
Pages 782-786 | Received 09 Mar 2006, Accepted 23 Jun 2006, Published online: 20 Jan 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. J. Weiss, V. A. Cueto-Vilorio, R. Dharmaraj, D. Barolia, A. Nashat, S. J. Walsh & S. E. Simpson. (2020) Characterization of intentional lurasidone ingestions using the United States National Poison Data System. Clinical Toxicology 58:12, pages 1342-1346.
Read now

Articles from other publishers (15)

Jared W. Castle, Danielle M. Butzbach, G. Stewart Walker, Claire E. Lenehan, Frank Reith, Samuel P. Costello & K. Paul Kirkbride. (2022) In vitro degradation of ziprasidone in human whole blood. Drug Testing and Analysis 15:2, pages 220-234.
Crossref
Margo Funk & Scott Beach. 2022. Torsades de Pointes. Torsades de Pointes 213 229 .
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 875 895 .
Mehrul Hasnain & W. Victor R. Vieweg. (2014) QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review. CNS Drugs 28:10, pages 887-920.
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine 695 727 .
Scott R. Beach, Christopher M. Celano, Peter A. Noseworthy, James L. Januzzi & Jeff C. Huffman. (2013) QTc Prolongation, Torsades de Pointes, and Psychotropic Medications. Psychosomatics 54:1, pages 1-13.
Crossref
Michael Levine & Anne-Michelle Ruha. (2012) Overdose of Atypical Antipsychotics. CNS Drugs 26:7, pages 601-611.
Crossref
Joanne C. Witsil, Michele Zell-Kanter & Mark B. Mycyk. (2012) Single-dose ziprasidone associated with QT interval prolongation. The American Journal of Emergency Medicine 30:5, pages 837.e1-837.e2.
Crossref
Domniki Fragou, Spyridoula Dotsika, Parthena Sarafidou, Victoria Samanidou, Samuel Njau & Leda Kovatsi. (2012) Atypical antipsychotics: trends in analysis and sample preparation of various biological samples. Bioanalysis 4:8, pages 961-980.
Crossref
Hossein Sanaei-Zadeh. (2012) QT interval—what is normal? Comment on “Single-dose ziprasidone associated with QT interval prolongation”. The American Journal of Emergency Medicine 30:4, pages 627.
Crossref
Catherine A. Harrington & Clayton English. (2012) Adverse Drug Events Related to Ziprasidone: A Meta‐analysis of Randomized, Placebo‐Controlled Trials. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:9, pages 840-849.
Crossref
Chip Gresham & Anne M. Ruha. (2010) Respiratory Failure Following Isolated Ziprasidone Ingestion in a Toddler. Journal of Medical Toxicology 6:1, pages 41-43.
Crossref
W. Victor R. Vieweg, Mark A. Wood, Antony Fernandez, Mary Beatty-Brooks, Mehrul Hasnain & Anand K. Pandurangi. (2009) Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs. Drugs & Aging 26:12, pages 997-1012.
Crossref
David Taylor, Carol Paton & Shitij Kapur. 2009. The Maudsley Prescribing Guidelines, Tenth Edition. The Maudsley Prescribing Guidelines, Tenth Edition 464 516 .
Charles J. Fasano, Gerald F. O'Malley, Claudia Lares & Adam K. Rowden. (2009) Pediatric Ziprasidone Overdose. Pediatric Emergency Care 25:4, pages 258-259.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.